NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's disease

Konstantin Chegaev, Antonella Federico, Elisabetta Marini, Barbara Rolando, Roberta Fruttero, Michela Morbin, Giacomina Rossi, Valeria Fugnanesi, Antonio Bastone, Mario Salmona, Nahuai B. Badiola, Laura Gasparini, Sara Cocco, Cristian Ripoli, Claudio Grassi, Alberto Gasco

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

18 Citazioni (Scopus)


Some symmetrical and unsymmetrical thiacarbocyanines bearing NO-donor nitrooxy and furoxan moieties were synthesized and studied as candidate anti-Alzheimer's drugs. All products activated soluble guanylate cyclase (sGC) in a dose-dependent manner, depending on the presence in their structures of NO-donor groups. None displayed toxicity when tested at concentrations below 10μM on human brain microvascular endothelial cells (hCMEC/D3). Some products were capable of inhibiting amyloid β-protein (Aβ) aggregation, with a potency in the low μM concentration range, and of inhibiting aggregation of human recombinant tau protein in amyloid fibrils when incubated with the protein at 1μM concentration. Nitrooxy derivative 21 and furoxan derivative 22 were selected to investigate synaptic plasticity. Both products, tested at 2μM concentration, counteracted the inhibition of long-term potentiation (LTP) induced by Aβ42 in hippocampal brain slices.
Lingua originaleEnglish
pagine (da-a)4688-4698
Numero di pagine11
Stato di pubblicazionePubblicato - 2015


  • Alzheimer disease
  • Long term potentiation
  • Nitric oxide
  • Tau proteins
  • Thiacarbocyanines
  • β-Amyloid


Entra nei temi di ricerca di 'NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's disease'. Insieme formano una fingerprint unica.

Cita questo